decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / 220.6.9
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare National Coverage Determination related to FDG-PET use for refractory seizures. It is relevant to clinicians, coding and billing professionals, and compliance teams who need to understand the coverage scope, the effective date, and the documentation expectations associated with this policy update.
Why This Topic Matters
Coverage determinations affect whether services are considered payable under Medicare and whether supporting documentation should be present in the medical record. Understanding this policy helps staff assess whether the article applies to a particular pre-surgical evaluation scenario and whether the Medicare coverage framework has changed.
What You Will Learn
- The Medicare coverage context for FDG-PET in refractory seizure evaluation
- The effective date associated with the policy
- The general limitation and documentation themes discussed in the coverage guidance
- How this National Coverage Determination is framed within the Medicare manual
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Physicians
- Revenue cycle staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com